Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Monopar Therapeutics

MNPR · Nasdaq · CIK 0001645469 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

46 Form 4 transaction lines observed in the same window
26 sales · 20 option, withholding, award, gift or other lines

Last qualifying purchase2025-12-26 · Vu Quan Anh · $104.9K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Robinson ChandlerChief Executive Officer
○○○▼○○
Vu Quan AnhChief Financial Officer
○○○○
Cittadine AndrewChief Operating Officer
○○○○
Tsuchimoto Kim RDirector
○▼▼
Anderson RaymondDirector
○▼▼
RIOUX PATRICEOther
○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-12-26 · Vu Quan Anh.

Recent Form 4 activity

1Purchases
28Sales
26Other Form 4 lines
19SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING26 sale line(s) · context only
OTHER20 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
1,086,279
Previous report
844,226
Avg daily volume
180,448
Days to cover
6.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-12-26Vu Quan AnhPurchase (P)Common Stock1,500USD 69.95USD 104,925SEC filing ↗
2024-10-28Radhakrishnan KarthikPurchase (P)Common Stock1,550USD 16.25USD 25,188SEC filing ↗
2024-06-20Cittadine AndrewPurchase (P)Common Stock20,508USD 0.74USD 15,176SEC filing ↗
2024-06-18Cittadine AndrewPurchase (P)Common Stock12,000USD 0.86USD 10,320SEC filing ↗
2024-06-17Cittadine AndrewPurchase (P)Common Stock12,000USD 0.90USD 10,800SEC filing ↗
2024-06-14Cittadine AndrewPurchase (P)Common Stock12,000USD 0.93USD 11,160SEC filing ↗
2024-06-13Cittadine AndrewPurchase (P)Common Stock12,000USD 0.91USD 10,920SEC filing ↗
2024-06-04Cittadine AndrewPurchase (P)Common Stock12,000USD 0.78USD 9,360SEC filing ↗
2024-06-03Cittadine AndrewPurchase (P)Common Stock12,000USD 0.76USD 9,120SEC filing ↗
2024-05-31Cittadine AndrewPurchase (P)Common Stock12,000USD 0.64USD 7,680SEC filing ↗
2024-05-30Cittadine AndrewPurchase (P)Common Stock12,000USD 0.64USD 7,680SEC filing ↗
2024-05-29Cittadine AndrewPurchase (P)Common Stock12,000USD 0.64USD 7,680SEC filing ↗
2022-11-15Cittadine AndrewPurchase (P)Common Stock10,000USD 3.15USD 31,500SEC filing ↗
2022-11-14Cittadine AndrewPurchase (P)Common Stock6,053USD 3.00USD 18,159SEC filing ↗

Form 4 evidence

55 transaction lines in the latest 365-day window; 268 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01STARR CHRISTOPHER MSale (S)Common Stock8,400USD 78.50USD 659,387SEC filing ↗
2026-10-01STARR CHRISTOPHER MOption exercise / conversion (M)Common Stock8,400USD 0.01USD 42SEC filing ↗
2026-09-30Vu Quan AnhOption exercise / conversion (M)Common Stock614USD —USD —SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-01STARR CHRISTOPHER MSale (S)Common Stock8,400USD 78.50USD 659,387SEC filing ↗
2026-10-01STARR CHRISTOPHER MOption exercise / conversion (M)Common Stock8,400USD 0.01USD 42SEC filing ↗
2026-09-30Vu Quan AnhOption exercise / conversion (M)Common Stock614USD —USD —SEC filing ↗
2026-09-30Vu Quan AnhTax withholding (F)Common Stock180USD 79.67USD 14,341SEC filing ↗
2026-09-30Robinson ChandlerOption exercise / conversion (M)Common Stock9,801USD —USD —SEC filing ↗
2026-09-30Robinson ChandlerTax withholding (F)Common Stock4,344USD 79.67USD 346,086SEC filing ↗
2026-09-30Cittadine AndrewOption exercise / conversion (M)Common Stock4,384USD —USD —SEC filing ↗
2026-09-30Cittadine AndrewTax withholding (F)Common Stock1,944USD 79.67USD 154,878SEC filing ↗
2026-09-24Robinson ChandlerSale (S)Common Stock29,056USD 88.00USD 2,556,851SEC filing ↗
2026-09-24Robinson ChandlerOption exercise / conversion (M)Common Stock29,056USD 21.74USD 631,680SEC filing ↗
2026-08-26Tsuchimoto Kim RSale (S)Common Stock4,090USD 111.39USD 455,567SEC filing ↗
2026-08-26Tsuchimoto Kim ROption exercise / conversion (M)Common Stock4,090USD 22.04USD 90,140SEC filing ↗
2026-08-26Tsuchimoto Kim RSale (S)Common Stock4,090USD 111.39USD 455,567SEC filing ↗
2026-08-26RIOUX PATRICESale (S)Common Stock1USD 111.26USD 111SEC filing ↗
2026-08-26RIOUX PATRICEOption exercise / conversion (M)Common Stock1,380USD 0.01USD 14SEC filing ↗
2026-08-25Anderson RaymondSale (S)Common Stock3,142USD 111.98USD 351,835SEC filing ↗
2026-08-25Anderson RaymondOption exercise / conversion (M)Common Stock3,142USD 30.00USD 94,260SEC filing ↗
2026-08-25Anderson RaymondSale (S)Common Stock3,142USD 111.77USD 351,189SEC filing ↗
2026-06-30Vu Quan AnhOption exercise / conversion (M)Common Stock1,228USD —USD —SEC filing ↗
2026-06-30Vu Quan AnhTax withholding (F)Common Stock507USD 92.59USD 46,943SEC filing ↗
2026-06-30Robinson ChandlerOption exercise / conversion (M)Common Stock12,873USD —USD —SEC filing ↗
2026-06-30Robinson ChandlerTax withholding (F)Common Stock4,084USD 92.59USD 378,138SEC filing ↗
2026-06-30Cittadine AndrewOption exercise / conversion (M)Common Stock5,254USD —USD —SEC filing ↗
2026-06-30Cittadine AndrewTax withholding (F)Common Stock2,309USD 92.59USD 213,790SEC filing ↗
2025-12-31Robinson ChandlerOption exercise / conversion (M)Common Stock8,724USD —USD —SEC filing ↗
2025-12-31Robinson ChandlerTax withholding (F)Common Stock2,558USD 65.30USD 167,037SEC filing ↗
2025-12-31Cittadine AndrewOption exercise / conversion (M)Common Stock4,326USD —USD —SEC filing ↗
2025-12-31Cittadine AndrewTax withholding (F)Common Stock1,889USD 65.30USD 123,352SEC filing ↗
2025-12-26Vu Quan AnhPurchase (P)Common Stock1,500USD 69.95USD 104,925SEC filing ↗
2025-12-18KLAUSNER ARTHUR JSale (S)Common Stock5,121USD 67.15USD 343,889SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerMNPR
CIK0001645469
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history268 transaction lines from 2020-03-31 to 2026-10-01
14 P purchase lines · 38 S sale lines · 216 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.